Last update 09 Nov 2024

Lobeglitazone/Sitagliptin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Sitagliptin/lobeglitazone, CKD-396
Target
DPP-4 x PPARα x PPARγ
Mechanism
DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PPARα agonists(Peroxisome proliferator-activated receptor α agonists), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Originator Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Active Organization-
Inactive Organization
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC16H20F6N5O6P
InChIKeyGQPYTJVDPQTBQC-KLQYNRQASA-N
CAS Registry654671-77-9
View All Structures (2)

Related

1
Clinical Trials associated with Lobeglitazone/Sitagliptin
NCT04246190 / Unknown statusPhase 1
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-396 and Co-administration of CKD-501 and D759 in Healthy Adults
100 Clinical Results associated with Lobeglitazone/Sitagliptin
Login to view more data
100 Translational Medicine associated with Lobeglitazone/Sitagliptin
Login to view more data
100 Patents (Medical) associated with Lobeglitazone/Sitagliptin
Login to view more data
100 Deals associated with Lobeglitazone/Sitagliptin
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 3
KR
Chong Kun Dang Pharmaceutical Corp.Chong Kun Dang Pharmaceutical Corp.
20 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free